Consequently, the pharmacological inhibitor of Gαq/11, YM-254,890 (Uemura et al. 2006b), was employed to investigate the therapeutic potential of targeting Gαq/11 in ALI. This evidence concerns the gene GNAQ and acute respiratory distress syndrome.